Jimit Medico Surgicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -23.04%
(FY 2022)
- Profit -40.62%
(FY 2022)
- Ebitda -38.92%
(FY 2022)
- Net Worth 16.96%
(FY 2022)
- Total Assets 20.20%
(FY 2022)
About Jimit Medico Surgicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mitesh Vyas, Alpa Vyas, and Shilp Vyas serve as directors at the Company.
- CIN/LLPIN
U33110GJ2013PTC074134
- Company No.
074134
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jimit Medico Surgicals Private Limited offer?
Jimit Medico Surgicals Private Limited offers a wide range of products and services, including Bandages & Dressing Disposables, Bandages, Physiotherapy & Rehab Aids, Rehabilitation Equipment, Medical & Surgical Clothing, Hospital Linen, Forceps & Graspers, Surgical Clamps, Surgical & ICU Equipments, Dialysis Machine.
Who are the key members and board of directors at Jimit Medico Surgicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shilp Vyas  | Director | 12-Jun-2020 | Current |
| Alpa Vyas | Director | 22-Mar-2013 | Current |
| Mitesh Vyas | Director | 22-Mar-2013 | Current |
Financial Performance and Corporate Structure Insights of Jimit Medico Surgicals.
Jimit Medico Surgicals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.04% decrease. The company also saw a substantial fall in profitability, with a 40.62% decrease in profit. The company's net worth Soared by an impressive increase of 16.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jimit Medico Surgicals?
Unlock access to Jimit Medico Surgicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jimit Medico Surgicals?
Jimit Medico Surgicals has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jimit Medico Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jimit Medico Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
